Hypertension is persistent elevation of systemic arterial blood pressure. Chronic high pressure increases mechanical stress on the heart and blood vessels and is associated with structural changes in the myocardium, arteries, kidneys, brain, and other organs.
Hypertension is persistent elevation of pressure within the systemic arterial circulation. Blood pressure is generated by the interaction between cardiac pumping and resistance within the vascular system, and sustained abnormalities in either can contribute to elevated arterial pressure.
Hypertension is especially important because it can remain clinically silent while progressively affecting the heart, arteries, brain, kidneys, and retina. Chronic pressure overload changes the structure of the cardiovascular system and increases the risk of coronary artery disease, heart failure, stroke, aortic disease, peripheral arterial disease, and chronic kidney disease.
The anatomical consequences of hypertension include left ventricular hypertrophy, thickening and remodeling of arterial walls, accelerated atherosclerosis, and injury to small vessels in susceptible organs.
Arterial blood pressure is the pressure exerted by circulating blood on the walls of systemic arteries.
It varies throughout the cardiac cycle and is commonly described using systolic and diastolic pressures.
Systolic blood pressure is the peak arterial pressure reached during ventricular systole.
It is influenced by left ventricular stroke volume, the rate of ventricular ejection, arterial compliance, and the properties of the systemic vascular system.
Diastolic blood pressure is the arterial pressure during ventricular relaxation between heartbeats.
It is strongly influenced by systemic vascular resistance, heart rate, and elastic recoil of large arteries.
Pulse pressure is the difference between systolic and diastolic blood pressure:
Pulse Pressure = Systolic Blood Pressure − Diastolic Blood Pressure
Pulse pressure is influenced by stroke volume and arterial compliance.
Mean arterial pressure (MAP) represents the average arterial pressure driving systemic blood flow during a cardiac cycle.
A commonly used approximation at normal heart rates is:
MAP ≈ Diastolic Pressure + 1/3 Pulse Pressure
Systemic arterial pressure depends primarily on cardiac output and systemic vascular resistance.
A simplified relationship is:
Mean Arterial Pressure ≈ Cardiac Output × Systemic Vascular Resistance
Cardiac output is the volume of blood pumped by a ventricle per unit time.
It is determined by heart rate and stroke volume:
Cardiac Output = Heart Rate × Stroke Volume
Systemic vascular resistance is the resistance encountered by blood flowing through the systemic circulation.
Small arteries and arterioles are major determinants of this resistance because changes in their luminal radius substantially alter resistance to flow.
Arterioles contain smooth muscle that can constrict or dilate in response to neural, hormonal, endothelial, and local metabolic signals.
Widespread arteriolar constriction increases systemic vascular resistance and tends to increase arterial pressure.
The aorta and other large elastic arteries expand during ventricular systole and recoil during diastole.
Loss of arterial elasticity with aging and vascular disease can increase systolic pressure and widen pulse pressure.
Circulating blood volume influences venous return, ventricular filling, cardiac output, and arterial pressure.
The kidneys play a central role in long-term regulation of blood volume through control of sodium and water excretion.
Rapid regulation of arterial pressure depends heavily on neural reflexes and changes in autonomic activity.
The arterial baroreceptor reflex is one of the most important short-term mechanisms.
Baroreceptors are stretch-sensitive sensory receptors located prominently in the carotid sinus and aortic arch.
Changes in arterial wall stretch alter afferent signaling to cardiovascular control centers in the brainstem.
When arterial pressure falls, reduced baroreceptor firing promotes increased sympathetic and reduced parasympathetic activity.
This can increase heart rate, myocardial contractility, arteriolar constriction, and venous tone, helping restore arterial pressure.
Long-term control of blood pressure is closely linked to renal regulation of sodium, extracellular fluid volume, and blood volume.
Neurohormonal systems modify these renal and vascular mechanisms.
The renin-angiotensin-aldosterone system (RAAS) participates in regulation of arterial pressure and extracellular fluid volume.
Renin release initiates a pathway that generates angiotensin II and promotes aldosterone secretion.
Angiotensin II is a potent vasoactive peptide that promotes vasoconstriction and influences renal sodium handling.
It also stimulates aldosterone secretion and participates in cardiovascular remodeling when chronically activated.
Aldosterone promotes renal sodium retention, with accompanying effects on extracellular fluid volume.
Excessive aldosterone activity can contribute to hypertension in certain disorders.
The sympathetic nervous system influences arterial pressure through effects on heart rate, cardiac contractility, arteriolar tone, venous tone, and renal function.
Persistent increases in sympathetic activity can contribute to elevated blood pressure in some individuals.
Primary hypertension, also called essential hypertension, is elevated blood pressure without a single identifiable secondary cause.
It represents the large majority of hypertension and develops through interactions among genetic predisposition, renal sodium handling, vascular function, neurohormonal regulation, environmental factors, and aging.
Secondary hypertension results from an identifiable underlying disorder or substance.
Potential causes include renal disease, renovascular disease, endocrine disorders, obstructive sleep apnea, certain medications, and vascular abnormalities such as coarctation of the aorta.
| Feature | Primary Hypertension | Secondary Hypertension |
|---|---|---|
| Cause | Multifactorial without one specific underlying cause | Identifiable underlying condition or exposure |
| Frequency | Majority of cases | Minority of cases |
| Mechanisms | Genetic, renal, vascular, neural and environmental interactions | Depends on underlying disorder |
| Management principle | Blood pressure reduction and cardiovascular risk management | Treatment of blood pressure plus underlying cause when possible |
Isolated systolic hypertension refers to elevation of systolic pressure while diastolic pressure remains below the diagnostic threshold used for diastolic hypertension.
It is particularly associated with reduced compliance of large arteries and becomes increasingly common with advancing age.
Elastic arteries normally buffer the pulsatile output of the left ventricle.
When the arterial wall becomes stiffer, systolic pressure tends to rise because the vessel expands less during ventricular ejection.
Persistent hypertension produces structural adaptation within the arterial system.
Small arteries and arterioles may develop increased wall thickness and altered lumen dimensions, contributing to persistent elevation of vascular resistance.
Hyaline arteriolosclerosis is characterized by homogeneous thickening of small arterial and arteriolar walls with narrowing of the lumen.
It is associated with chronic hypertension and diabetes mellitus and can contribute to ischemic injury in affected tissues.
Severe hypertension can produce hyperplastic arteriolosclerosis, characterized by concentric thickening of arteriolar walls.
In very severe disease, vascular injury may be accompanied by fibrinoid necrosis.
Systemic hypertension increases the pressure against which the left ventricle must eject blood.
This chronic increase in afterload places sustained mechanical stress on the ventricular myocardium.
The left ventricle can adapt to chronic pressure overload by developing left ventricular hypertrophy (LVH).
Myocardial wall thickness increases, helping the ventricle generate greater pressure while initially limiting wall stress.
Pressure overload commonly produces a pattern of concentric hypertrophy, with increased ventricular wall thickness relative to chamber size.
Although initially adaptive, excessive hypertrophy can impair ventricular relaxation and increase myocardial oxygen requirements.
A hypertrophied left ventricle may become less compliant.
Reduced ventricular compliance can impair diastolic filling and increase left ventricular filling pressures, contributing to heart failure with preserved ejection fraction.
Long-standing pressure overload can eventually exceed compensatory mechanisms.
Myocardial fibrosis, ischemia, altered chamber geometry, and progressive ventricular dysfunction can contribute to clinical heart failure.
Hypertension is an important risk factor for atherosclerotic coronary artery disease.
At the same time, increased ventricular mass raises myocardial oxygen demand, potentially worsening the consequences of limited coronary blood flow.
Chronic hypertension damages large and small vessels supplying the brain.
It is a major risk factor for both ischemic and hemorrhagic stroke.
Hypertensive injury to small penetrating cerebral arteries can produce structural changes that increase susceptibility to occlusion and hemorrhage.
Chronic small vessel disease can also contribute to cumulative cerebral tissue injury.
Long-standing hypertension can weaken small cerebral vessels.
Rupture of affected vessels can produce intracerebral hemorrhage, particularly in characteristic deep brain locations.
The kidneys both regulate blood pressure and are targets of hypertensive vascular injury.
Chronic hypertension can damage renal arterioles, glomeruli, and interstitial tissue, progressively impairing renal function.
Hypertensive nephrosclerosis refers to renal vascular and parenchymal changes associated with chronic hypertension.
Narrowing of small renal vessels can reduce blood flow and contribute to chronic ischemic injury.
The relationship between hypertension and kidney disease is bidirectional.
Hypertension can damage the kidneys, while renal disease can cause or worsen hypertension through abnormalities of sodium balance, volume regulation, and neurohormonal pathways.
The retinal circulation allows direct clinical observation of small blood vessels.
Chronic or severe hypertension can produce narrowing of retinal arterioles, vascular wall changes, hemorrhages, exudates, and, in severe cases, optic disc swelling.
Hypertension increases mechanical stress on the aortic wall.
It is associated with increased risk of major aortic disease, including aortic dissection and aneurysmal complications in susceptible individuals.
Aortic dissection occurs when blood enters the aortic wall and separates its layers.
Chronic hypertension is an important predisposing factor because sustained pressure contributes to stress and degeneration within the aortic wall.
Hypertension contributes to atherosclerotic disease in arteries supplying the limbs.
It therefore increases the risk of peripheral arterial disease and its associated ischemic complications.
| Organ or System | Potential Hypertensive Effect |
|---|---|
| Heart | Left ventricular hypertrophy, coronary disease and heart failure |
| Brain | Ischemic stroke, intracerebral hemorrhage and small vessel disease |
| Kidneys | Nephrosclerosis and chronic kidney disease |
| Retina | Hypertensive retinopathy |
| Aorta | Increased risk of dissection and aneurysmal complications |
| Peripheral arteries | Accelerated atherosclerosis and peripheral arterial disease |
Risk factors for primary hypertension include increasing age, family history and genetic predisposition, excess dietary sodium in susceptible individuals, excess body weight, physical inactivity, and other metabolic and environmental factors.
Multiple factors frequently occur together and interact over time.
Hypertension is frequently asymptomatic, particularly during its earlier stages.
For this reason, measurement of blood pressure is necessary to identify persistent elevation before major target-organ complications occur.
Accurate blood pressure assessment requires appropriate technique, including suitable cuff size, correct positioning, and repeated measurements when establishing a diagnosis.
Because blood pressure varies with activity, stress, sleep, posture, medications, and other factors, a single reading does not always represent a person's usual pressure.
Blood pressure can be measured in a clinical setting using validated equipment.
Repeated measurements on separate occasions are commonly used to determine whether elevation is persistent.
Home measurements provide blood pressure information outside the clinical environment.
When performed with a validated device and appropriate technique, they can help assess usual blood pressure and response to treatment.
Ambulatory blood pressure monitoring records blood pressure repeatedly over an extended period during normal daily activities and sleep.
It provides information about daytime, nighttime, and overall blood pressure patterns.
White coat hypertension describes elevated blood pressure in a clinical environment with lower measurements outside that setting.
Out-of-office measurements can help identify this pattern.
Masked hypertension describes blood pressure that appears normal in the clinical setting but is elevated outside the clinic.
Home or ambulatory monitoring can help detect this pattern.
Severe elevations in blood pressure require assessment for evidence of acute target-organ injury.
The clinical significance depends not only on the measured pressure but also on whether acute injury is occurring in organs such as the brain, heart, kidneys, retina, or aorta.
A hypertensive emergency involves severe blood pressure elevation accompanied by acute hypertension-mediated organ damage.
Potential manifestations include hypertensive encephalopathy, acute heart failure, acute coronary syndromes, acute kidney injury, aortic dissection, and other critical vascular complications.
Severely elevated blood pressure without acute target-organ injury has historically been described as hypertensive urgency.
The distinction from hypertensive emergency is based primarily on the presence or absence of acute organ damage rather than the pressure value alone.
Evaluation generally includes confirmation of persistent blood pressure elevation, assessment of cardiovascular risk, examination for target-organ damage, and consideration of possible secondary causes.
Features such as unusual age of onset, abrupt worsening, resistant hypertension, characteristic laboratory abnormalities, or specific clinical findings may prompt investigation for a secondary cause.
Narrowing of a renal artery can reduce perfusion pressure to the affected kidney.
Activation of the renin-angiotensin-aldosterone system can then contribute to systemic hypertension.
Excessive autonomous aldosterone production promotes sodium retention and can increase arterial pressure.
It is an important potentially identifiable cause of secondary hypertension.
Pheochromocytoma is a catecholamine-producing tumor that can cause sustained or episodic hypertension through excessive adrenergic stimulation.
Coarctation of the aorta is congenital narrowing of the aorta.
The obstruction can produce elevated arterial pressure proximal to the narrowing and reduced pressure in vessels distal to it.
Management of hypertension aims to reduce arterial pressure and lower the risk of cardiovascular, cerebrovascular, renal, and other complications.
The approach depends on blood pressure severity, associated diseases, overall cardiovascular risk, and potential secondary causes.
Nonpharmacological measures can contribute to blood pressure reduction and overall cardiovascular risk management.
These may include dietary changes, appropriate sodium reduction, regular physical activity, weight management, moderation of alcohol intake, and avoidance of tobacco exposure.
Several medication classes lower blood pressure through different physiological mechanisms.
Major approaches include reducing vascular resistance, altering renal sodium and water handling, modifying the renin-angiotensin system, or reducing sympathetic and cardiac influences.
Diuretics increase renal sodium excretion and can reduce extracellular fluid volume.
Long-term antihypertensive effects also involve changes in vascular resistance.
These medications reduce the effects of the renin-angiotensin system through different mechanisms.
They can lower vascular resistance and modify renal and cardiovascular responses to angiotensin II.
Calcium channel blockers can reduce arterial smooth muscle contraction, and some agents also affect cardiac rate and conduction.
Their specific cardiovascular effects depend on the drug subclass.
Beta-adrenergic blockers reduce selected effects of sympathetic stimulation on the cardiovascular system.
Depending on the agent and clinical context, they can reduce heart rate, contractility, and renin release.
The effects of hypertension accumulate over time. Persistent pressure increases cardiac workload and exposes arterial walls and microvascular beds to chronic mechanical stress.
Reducing sustained blood pressure decreases the risk of major cardiovascular and renal complications.
| Condition | Relationship to Hypertension |
|---|---|
| Left ventricular hypertrophy | Adaptation to chronic pressure overload |
| Heart failure | Can follow hypertrophy, diastolic dysfunction or progressive ventricular impairment |
| Coronary artery disease | Hypertension accelerates vascular injury and atherosclerotic risk |
| Stroke | Increases risk of ischemic and hemorrhagic cerebrovascular events |
| Chronic kidney disease | Chronic vascular injury damages renal tissue |
| Aortic disease | Increased wall stress contributes to major aortic complications |
| Feature | Key Point |
|---|---|
| Definition | Persistent elevation of systemic arterial blood pressure |
| Major hemodynamic determinants | Cardiac output and systemic vascular resistance |
| Major long-term regulator | Kidneys through sodium and fluid balance |
| Major resistance vessels | Small arteries and arterioles |
| Common form | Primary hypertension |
| Cardiac adaptation | Left ventricular hypertrophy |
| Important vascular effect | Arterial remodeling and accelerated vascular disease |
| Major target organs | Heart, brain, kidneys, retina and arteries |
Hypertension demonstrates the close relationship between arterial pressure, vascular structure, and cardiac workload. Sustained elevation of systemic pressure forces the left ventricle to generate greater pressure during each contraction and exposes the arterial tree to increased mechanical stress.
Over time, these forces produce anatomical adaptation and injury. The left ventricular wall can hypertrophy, small arteries can thicken and narrow, large arteries can become stiffer, and susceptible microvascular beds in the kidneys, brain, and retina can undergo progressive damage.
These structural changes can also reinforce the disease process. Increased vascular resistance, arterial stiffness, renal injury, and neurohormonal activation can make blood pressure more difficult to regulate, while cumulative target-organ damage increases the likelihood of major cardiovascular complications.